A Computational, Tissue-Realistic Model of Pressure Ulcer Formation in Individuals with Spinal Cord Injury

PLoS Computational Biology

Volumn 11, Issue 6, 2015, Pages

  Ziraldo, Cordelia ^a,b   Solovyev, Alexey ^b   Allegretti, Ana ^b   Krishnan, Shilpa ^b   Henzel, M Kristi ^c   Sowa, Gwendolyn A ^a   Brienza, David ^b,d   An, Gary ^b,e   Mi, Qi ^b   Vodovotz, Yoram ^b,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d PA 15260   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMOUS AGENTS; COMPUTATIONAL METHODS; DISEASES; PATHOLOGY; PATIENT REHABILITATION; TISSUE;

AGENT-BASED MODEL; IN-SILICO; ISCHAEMIA-REPERFUSION; MECHANISTICS; PRESSURE ULCERS; QUALITY OF LIFE; REALISTIC MODEL; SERIAL IMAGES; SPINAL CORD INJURY; TISSUE LEVELS;

SENSITIVITY ANALYSIS;

BIOLOGICAL FACTOR; CORTICOSTEROID; DAMAGE ASSOCIATED MOLECULAR PATTERN MOLECULE; NEUTRALIZING ANTIBODY; OXYGEN; UNCLASSIFIED DRUG; CHEMOTACTIC FACTOR;

ADULT; ARTICLE; CALIBRATION; CELL COUNT; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER SIMULATION; CONTROLLED STUDY; DECUBITUS; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MEDIATOR RELEASE; PATHOGENESIS; SPINAL CORD INJURY; TISSUE INJURY; ALGORITHM; BIOLOGICAL MODEL; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY; PRESSURE; PRESSURE ULCER;

ALGORITHMS; CHEMOTACTIC FACTORS; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; PRESSURE; PRESSURE ULCER; SPINAL CORD INJURIES;

EID: 84953790814     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004309     Document Type: Article

References (63)

1. Regan MA, Teasell RW, Wolfe DL, Keast D, Mortenson WB, Aubut JA, A systematic review of therapeutic interventions for pressure ulcers after spinal cord injury. Arch Phys Med Rehabil 2009;90(2):213–31. doi: 10.1016/j.apmr.2008.08.212 19236976
2. Bates-Jensen BM, Guihan M, Garber SL, Chin AS, Burns SP, Characteristics of recurrent pressure ulcers in veterans with spinal cord injury. The journal of spinal cord medicine 2009;32(1):34–42. 19264047
3. Bao F, Bailey CS, Gurr KR, Bailey SI, Rosas-Arellano MP, Dekaban GA, et al. Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Experimental neurology 2009;215(2):308–16. doi: 10.1016/j.expneurol.2008.10.022 19056384
4. Frost F, Roach MJ, Kushner I, Schreiber P, Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil 2005;86(2):312–7. 15706560
5. Segal JL, Gonzales E, Yousefi S, Jamshidipour L, Brunnemann SR, Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Arch Phys Med Rehabil 1997;78(1):44–7. 9014956
6. Edlich RF, Winters KL, Woodard CR, Buschbacher RM, Long WB, Gebhart JH, et al. Pressure ulcer prevention. J Long Term Eff Med Implants 2004;14(4):285–304. 15447627
7. Houwing R, Overgoor M, Kon M, Jansen G, Van Asbeck BS, Haalboom JRE, Pressure-induced skin lesions in pigs: reperfusion injury and the effects of vitamin E. Journal of wound care 2000;9(1):36–40. 10827667
8. Peirce SM, Skalak TC, Rieger JM, Macdonald TL, Linden J, Selective A2A adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol Heart Circ Physiol 2001;281(1):H67–H74. 11406470
9. Vodovotz Y, Translational systems biology of inflammation and healing. Wound Repair Regen 2010 Jan;18(1):3–7. doi: 10.1111/j.1524-475X.2009.00566.x 20082674
10. An G, Closing the scientific loop: bridging correlation and causality in the petaflop age. Sci Transl Med 2010;2(41):41ps34. doi: 10.1126/scitranslmed.3000390 20650869
11. An G, Christley S, Addressing the Translational Dilemma: Dynamic Knowledge Representation of Inflammation using Agent-based Modeling. Crit Rev Biomed Eng 2012 Aug 1.
12. Vodovotz Y, An G, Vodovotz Y, An G, An Overview of the Translational Dilemma and the Need for Translational Systems Biology of Inflammation. In: Complex Systems and Computational Biology Approaches to Acute Inflammation.New York: Springer; 2013. p. 1–7.
13. Ayello EA, Lyder C, A new era of pressure ulcer accountability in acute care. Adv Skin Wound Care 2008;21(3):134–40. doi: 10.1097/01.ASW.0000305421.81220.e6 18388668
14. Armstrong DG, Ayello EA, Capitulo KL, Fowler E, Krasner DL, Levine JM, et al. New opportunities to improve pressure ulcer prevention and treatment: implications of the CMS inpatient hospital care present on admission indicators/hospital-acquired conditions policy: a consensus paper from the International Expert Wound Care Advisory Panel. Adv Skin Wound Care 2008;21(10):469–78. doi: 10.1097/01.ASW.0000323562.52261.40 18836326
15. Regan MA, Teasell RW, Wolfe DL, Keast D, Mortenson WB, Aubut JA, A systematic review of therapeutic interventions for pressure ulcers after spinal cord injury. Arch Phys Med Rehabil 2009;90(2):213–31. doi: 10.1016/j.apmr.2008.08.212 19236976
16. Salcido R, Popescu A, Ahn C, Animal models in pressure ulcer research. The journal of spinal cord medicine 2007;30(2):107–16. 17591222
17. Lindblad WJ, Considerations for selecting the correct animal model for dermal wound-healing studies. J Biomater Sci Polym Ed 2008;19(8):1087–96. doi: 10.1163/156856208784909390 18644233
18. Dorsett-Martin WA, Rat models of skin wound healing: a review. Wound Repair Regen 2004 Nov;12(6):591–9. 15555049
19. An G, Mi Q, Dutta-Moscato J, Solovyev A, Vodovotz Y, Agent-based models in translational systems biology. WIRES 2009;1:159–71.
20. Vodovotz Y, Csete M, Bartels J, Chang S, An G, Translational systems biology of inflammation. PLoS Comput Biol 2008;4:1–6.
21. Vodovotz Y, An G, Complex Systems and Computational Biology Approaches to Acute Inflammation. Springer; 2013.
22. Mi Q, Solovyev A, Zhou L, Mikheev M, Dutta-Moscato J, An G, et al. A computer simulation of pressure ulcer formation following spinal cord injury: An application of a novel agent-based biomedical modeling framework. Proceedings of RESNA 2009 Annual Conference; 2009.
23. Chow WW, Deformations and stresses in soft body tissures of a sitting person. J Biomech Eng 1978;100:79–87.
24. Makhsous M, Lim D, Hendrix R, Bankard J, Rymer WZ, Lin F, Finite element analysis for evaluation of pressure ulcer on the buttock: development and validation. IEEE Trans Neural Syst Rehab Eng 2007;15(4):517–25. doi: 10.1109/TNSRE.2007.906967 18198709
25. Solovyev A, Mi Q, Tzen YT, Brienza D, Vodovotz Y, Hybrid equation/agent-based model of ischemia-induced hyperemia and pressure ulcer formation predicts greater propensity to ulcerate in subjects with spinal cord injury. PLoS Comput Biol 2013;9(5):e1003070. doi: 10.1371/journal.pcbi.1003070 23696726
26. Granger DN, Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 1988;255(6):H1269–H1275.
27. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. Journal of molecular and cellular cardiology 1985;17(2):145–52. 3839024
28. Mantovani A, Sica A, Locati M, Macrophage polarization comes of age. Immunity 2005;23(4):344–6. 16226499
29. Mosser DM, Edwards JP, Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008;8(12):958–69. doi: 10.1038/nri2448 19029990
30. Solovyev, A. and Mi, Q. Simple Platform for Agent-Based Representation of Knowledge (SPARK). 2012; Available: http://www.pitt.edu/~cirm/spark
31. Dutta-Moscato J, Solovyev A, Mi Q, Nishikawa T, Soto-Gutierrez A, Fox IJ, et al. A multiscale agent-based in silico model of liver fibrosis progression. Frontiers in bioengineering and biotechnology 2014;2.
32. Solovyev A, Mikheev M, Zhou L, Ziraldo C, An G, Mi Q, SPARK: A Framework for Multi-Scale Agent-Based Biomedical Modeling. Int J Agent Technol Syst 2010;2(3):18–30. 24163721
33. Bianchi ME, DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007 Jan;81(1):1–5. 17338044
34. Murray PJ, Wynn TA, Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011 Nov;11(11):723–37. doi: 10.1038/nri3073 21997792
35. Huang W, Vodovotz Y, Kusturiss MB, Barclay D, Greenwald K, Boninger ML, et al. Identification of distinct monocyte phenotypes and correlation with circulating cytokine profiles in acute response to spinal cord injury: a pilot study. PM&R: the journal of injury, function and rehabilitation 2014;6(4):332–41.
36. Hunt CA, Ropella GEP, ning Lam T, Gewitz AD, Relational grounding facilitates development of scientifically useful multiscale models. Theor Biol Med Model 2011;8(1):35.
37. Xing Z, Pei J, Philip SY, Early classification on time series. Knowledge and information systems 2012;31(1):105–27.
38. Peirce SM, Skalak TC, Rodeheaver GT, Ischemia-reperfusion injury in chronic pressure ulcer formation: A skin model in the rat. Wound Repair Regen 2000;8(1):68–76. 10760216
39. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF, Impaired wound healing. Clinics in Dermatology 2007 Jan;25(1):19–25. 17276197
40. Liddiard K, Rosas M, Davies LC, Jones SA, Taylor PR, Macrophage heterogeneity and acute inflammation. Eur J Immunol 2011 Sep 1;41(9):2503–8. doi: 10.1002/eji.201141743 21952806
41. Black J, Baharestani MM, Cuddigan J, Dorner B, Edsberg L, Langemo D, et al. National Pressure Ulcer Advisory Panel's updated pressure ulcer staging system. Adv Skin Wound Care 2007;20(5):269. 17473563
42. Berlowitz DR, Brienza DM, Are all pressure ulcers the result of deep tissue injury? A review of the literature. Ostomy/wound management 2007;53(10):34. 17978413
43. Marino S, Hogue IB, Ray CJ, Kirschner DE, A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 2008 Sep 7;254(1):178–96. doi: 10.1016/j.jtbi.2008.04.011 18572196
44. Saltelli A, Chan K, Scott EM, Sensitivity Analysis. Chichester, New York: Wiley; 2000.
45. Chang ST, Linderman JJ, Kirschner DE, Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. Proc Natl Acad Sci U S A 2005;102(12):4530–5. 15767567
46. Ray JC, Flynn JL, Kirschner DE, Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection. J Immunol 2009 Mar 15;182(6):3706–17. doi: 10.4049/jimmunol.0802297 19265149
47. Segovia-Juarez JL, Ganguli S, Kirschner D, Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol 2004 Dec 7;231(3):357–76. 15501468
48. Nagaraja S, Wallqvist A, Reifman J, Mitrophanov AY, Computational Approach To Characterize Causative Factors and Molecular Indicators of Chronic Wound Inflammation. J Immunol 2014;1824–34. doi: 10.4049/jimmunol.1302481 24453259
49. Pappalardo F, Pennisi M, Ricupito A, Topputo F, Bellone M, Induction of T-cell memory by a dendritic cell vaccine: a computational model. Bioinformatics 2014 Mar 6;30(13):1884–91. doi: 10.1093/bioinformatics/btu059 24603984
50. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Armstrong DG, Harkless LB, et al. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabetic Medicine 2001 Feb 1;18(2):133–8. 11251677
51. Sullivan R, A Two-year Retrospective Review of Suspected Deep Tissue Injury Evolution in Adult Acute Care Patients. Ostomy/wound management 2013;59(9):30–9. 24018390
52. Halfens RJG, Bours GJJW, Van Ast W, Relevance of the diagnosis 'stage 1 pressure ulcers': an empirical study of the clinical course of stage 1 ulcers in acute care and long-term care hospital populations. Journal of Clinical Nursing 2001 Nov 14;10(6):748–57. 11822846
53. Gong C, Linderman JJ, Kirschner D, Harnessing the heterogeneity of T cell differentiation fate to fine-tune generation of effector and memory T cells. Frontiers in immunology 2014;5.
54. Nathan C, Points of control in inflammation. Nature 2002 Dec 19;420(6917):846–52. 12490957
55. Clermont G, Bartels J, Kumar R, Constantine G, Vodovotz Y, Chow C, In silico design of clinical trials: a method coming of age. CCM 2004;32:2061–70.
56. An G, In-silico experiments of existing and hypothetical cytokine-directed clinical trials using agent based modeling. CCM 2004;32:2050–60.
57. Mi Q, Rivière B, Clermont G, Steed DL, Vodovotz Y, Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-b1. Wound Rep Regen 2007;15:617–82. 17971006
58. Kumar R, Chow CC, Bartels J, Clermont G, Vodovotz Y, A mathematical simulation of the inflammatory response to anthrax infection. Shock 2008;29:104–11. 18157069
59. Brown D, Namas RA, Almahmoud K, Zaaqoq A, Sarkar J, Barclay DA, et al. Trauma in silico: Individual-specific mathematical models and virtual clinical populations. Sci Transl Med 2015 Apr 29;7(285):285ra61. doi: 10.1126/scitranslmed.aaa3636 25925680
60. Yang H, Wang H, Czura CJ, Tracey KJ, HMGB1 as a cytokine and therapeutic target. Journal of endotoxin research 2002;8(6):469–72. 12697092
61. Andersson U, Tracey KJ, HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011 Apr 23;29:139–62. doi: 10.1146/annurev-immunol-030409-101323 21219181
62. An G, Small to large, lots to some, many to few: In silico navigation of the Translational Dilemma. CCM 2012;40(4):1334. doi: 10.1097/CCM.0b013e31824316dd 22425826
63. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2012;(4):CD004123.